WHO recommends Roche, Sanofi drugs for Covid-19 to cut death risk

A WHO group evaluating therapies concluded treating severe and critical COVID patients with these so-called interleukin-6 antagonists that block inflammation 'reduces the risk of death and the need for mechanical ventilation'

from mint - News https://ift.tt/36ofNBb
https://ift.tt/eA8V8J